BD Recasts Historical Financials Post-Spin-Off for Continuing Operations

summarizeSummary

Becton Dickinson provides recast historical financial data, presenting its spun-off business as discontinued operations to establish a clear financial baseline for its continuing business.

check_boxKey Events

• Recast Historical Financials

  Becton Dickinson furnished unaudited recast historical financial information, reflecting the Biosciences and Diagnostic Solutions business as discontinued operations.

• Post-Spin-Off Baseline

  This re-presentation provides a historical baseline of BD's standalone operating results from continuing operations, excluding specified items, following the February 9, 2026 spin-off.

• Non-GAAP Measures Included

  The furnished exhibit includes certain non-GAAP financial measures with adjustments for purchase accounting, integration, restructuring, transaction costs, and other items to aid in period-over-period comparability.

auto_awesomeAnalysis

Becton Dickinson has filed recast historical financial information to reflect its Biosciences and Diagnostic Solutions business as discontinued operations following the spin-off on February 9, 2026. This filing is crucial for investors and analysts to establish a new financial baseline for BD's continuing operations, enabling accurate year-over-year comparisons and future performance analysis. It provides transparency into the company's standalone financial health post-separation.